Subscribe Sign In

Home
Browse
Blog / Use Cases
About
Developer
Contact

Lung Cancer | Tracheoesophageal Fistula Associated with Chemoradiation and Bevacizumab Therapy

Purpose: To identify a patient with lung cancer who is at increased risk for a tracheoesophageal (TE) fistula as a result of bevacizumab therapy and chemoradiation.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with lung cancer?

Yes

No

Has the patient received chemoradiation for the lung cancer?

Yes

No

Has the patient been treated with bevacizumab?

Yes

No

Does the patient have esophagitis or other esophageal disease?

Yes

No

Is there evidence of direct extension of the lung cancer into the esophagus?

Yes

No

Has the patient had serious surgical or instrumentation injury to the trachea or esophagus?

Yes

No

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Is the patient at increased risk for a tracheoesophageal fistula from the lung cancer therapy?

Number of other explanations for a tracheosophageal fistula

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
- Daily Gut Score of Blijlevens et al for Gastrointestinal Toxicity Associated with Cancer Therapy
- Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
Criteria For Diagnosis
- Criteria for Complicated & Uncomplicated Chemotherapy-Induced Diarrhea
Severity, Prognosis, Stage
Complications
- Management of Chemotherapy Induced Diarrhea

Therapy

Prevention
- Recommendations for Prevention of Chronic Radiation Enteritis
- Management of Chemotherapy Induced Diarrhea
Interventional Radiology
- Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
- Risk Factors for Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer

Monitoring

Response To Therapy
- Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
- Risk Factors for Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
Adverse Effects

Specialty

Hematology Oncology
Gastroenterology

Objective

adverse effects

ICD-10

T45.1 - Poisoning, antineoplastic and immunosuppressive drugs

Info

Purpose: To identify a patient with lung cancer who is at increased risk for a tracheoesophageal (TE) fistula as a result of bevacizumab therapy and chemoradiation.

Specialty: Hematology Oncology, Gastroenterology

Objective: adverse effects

ICD-10: T45.1,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path

34,000 Evidence-Based Health Analytics for Education, Research, Clinical Decision Support, Documentation, EHR Integration and Data Analytics

Chest Pain HEART Score

Barthel Index of Independence of Patient for Mobility & Personal Care

Userful Links

Browse Tools
Our Company
Sample Calculators
User Guide
Subscription
Client Benefits
Blog / Use Cases
Management Team
Developer
Editorial Board
Contact Us

Contact us

address 95 Aldwych, London WC2B 4JF, United Kingdom
phoneUS: +1-818-445-5282
emailinfo@MedicalAlgorithms.com

Copyright © 2007 to 2024 The Medical Algorithms Company Limited | Terms and Conditions | Data Privacy Policy | Sitemap